Loading...

SAI - Detailed view

XEVUDY Inf Konz 500 mg/8ml Durchstf 8 ml

Drug

Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Behandlung von COVID-19
08.03.0. – antivirals

HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)

Z – approved
1/14/2022
3/18/2029

Dosage strength

Xevudy, Konzentrat zur Herstellung einer Infusionslösung
Behandlung von COVID-19
01
Z – approved

Package

7680684710018
No information made available
A/R – Authorised / referenced 

1 vial(s)

001
Z – approved

Declaration

Component

500 mg sotrovimabum
histidinum
histidini hydrochloridum monohydricum
saccharum
polysorbatum 80
methioninum
aqua ad iniectabile

Authorisation holder

7601001000674
GlaxoSmithKline AG
Talstrasse 3
3053 Münchenbuchsee (BE)

Date of revision of the text

4/1/2024

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.